Viridian Therapeutics, Inc.
P/S (Price-to-Sales)
Price
Sales Per Share
P/S (Price-to-Sales)
| Fiscal Year | P/S (Price-to-Sales) | Sales Per Share | Price |
|---|---|---|---|
| Dec 2014 | 333.40x | $0.57 | $190.50 |
| Dec 2015 | 20.91x | $2.68 | $56.10 |
| Dec 2016 | 11.18x | $2.24 | $25.05 |
| Dec 2017 | 882.03x | $0.06 | $52.15 |
| Dec 2018 | 167.14x | $0.09 | $15.15 |
| Dec 2019 | 3.75x | $0.64 | $2.40 |
| Dec 2020 | 66.29x | $0.08 | $5.48 |
| Dec 2021 | 26.51x | $0.25 | $6.59 |
| Dec 2022 | 176.31x | $0.06 | $9.74 |
| Dec 2023 | 3,104.38x | $0.01 | $21.78 |
| Dec 2024 | 5,141.24x | $0.00 | $19.17 |
| Dec 2025 | 44.58x | $0.70 | $31.02 |